Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

4.50
Delayed Data
As of Aug 15
 0.00 / 0.00%
Today’s Change
3.65
Today|||52-Week Range
7.15
-19.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line6.7M3.4M-1.5M6.0M
 
 
 
 
 
Depreciation919.1K2.0M1.9M1.9M
 
 
 
 
 
Total Other Cash Flow-325.2K228.0K1.8M1.2M
 
 
 
 
 
Funds From Operations7.4M6.2M2.2M9.1M
 
 
 
 
 
Funds From/For Other Operating Expenses282.5K-777.0K3.1M-2.1M
 
 
 
 
 
Net Cash Flow - Operating Activities7.1M6.9M-891.0K11.2M
 
 
 
 
 
 
InvestingDecrease In Investments15.4M0.000.000.00
 
 
Capital Expenditures-522.4K-2.0M-1.7M-3.6M
 
 
 
 
 
Net Assets From Acquisitions -14.5M0.000.000.00
 
 
Net Cash Flow Investing315.1K-2.0M-1.7M-3.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.00------
Long Term Debt Reduction-72.3K-245.0K-238.0K-226.0K
 
 
 
 
 
Net Proceeds Stock Sale10.7K33.0K82.0K0.00
 
 
 
 
Common Preferred Redeemed0.00-8.5M-22.0K0.00
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total-27.5K-28.0K-28.0K-28.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-89.1K-8.7M-206.0K-254.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash212.7K-85.0K-56.0K-275.0K
 
 
 
 
 
 
Net Change In Cash7.3M-3.9M-2.8M7.4M